Robert Godin

1.5k total citations
22 papers, 1.1k citations indexed

About

Robert Godin is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Robert Godin has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Robert Godin's work include Epigenetics and DNA Methylation (5 papers), Renal and related cancers (5 papers) and PARP inhibition in cancer therapy (3 papers). Robert Godin is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Renal and related cancers (5 papers) and PARP inhibition in cancer therapy (3 papers). Robert Godin collaborates with scholars based in United States, United Kingdom and Canada. Robert Godin's co-authors include Andrew T. Dudley, Elizabeth J. Robertson, Norma T. Takaesu, Michael L. Cleary, Catherine A. Schnabel, Tina Howard, Nicholas Keen, Nicholas Larsen, Andrew D. Ferguson and Huawei Chen and has published in prestigious journals such as Journal of Clinical Oncology, Genes & Development and Development.

In The Last Decade

Robert Godin

22 papers receiving 1.1k citations

Peers

Robert Godin

ONCOL

PRM

GENET

UROLO

Petra Kohlberger Austria

Ely Benaim United States

A M Schwartz United States

Julian Schardt Switzerland

Seema V. Garde India

Arnavaz Danesh Canada

Felix Bremmer Germany

Ingo Kausch Germany

Ilary Ruscito Italy

Olga E. Bryzgunova Russia

Petra Kohlberger Austria

Robert Godin

516 ×0.6

327 ×1.5

ONCOL

132 ×0.7

PRM

89 ×0.6

GENET

36 ×0.3

UROLO

Citations per year, relative to Robert Godin Robert Godin (= 1×) peers Petra Kohlberger

Countries citing papers authored by Robert Godin

Since Specialization

Citations

This map shows the geographic impact of Robert Godin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Godin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Godin more than expected).

Fields of papers citing papers by Robert Godin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Godin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Godin. The network helps show where Robert Godin may publish in the future.

Co-authorship network of co-authors of Robert Godin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Godin. A scholar is included among the top collaborators of Robert Godin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Godin. Robert Godin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shin, Young Joo, et al.. (2022). Effect of Phenobarbital on Elevated Direct Bilirubin Concentrations in Neonates and Infants in the Neonatal Intensive Care Unit. The Journal of Pediatric Pharmacology and Therapeutics. 27(6). 545–550. 1 indexed citations

Kahn, Doron J., et al.. (2022). Reducing Antibiotic Use in a Level III and Two Level II Neonatal Intensive Care Units Targeting Prescribing Practices for Both Early and Late-onset Sepsis: A Quality Improvement Project. Pediatric Quality and Safety. 7(3). e555–e555. 6 indexed citations

Westin, Shannon N., Robert L. Coleman, Bryan Fellman, et al.. (2021). EFFORT: EFFicacy Of adavosertib in parp ResisTance: A randomized two-arm non-comparative phase II study of adavosertib with or without olaparib in women with PARP-resistant ovarian cancer.. Journal of Clinical Oncology. 39(15_suppl). 5505–5505. 66 indexed citations

Godin, Robert, et al.. (2020). A comparison of the glycemic effects of glucagon using two dose ranges in neonates and infants with hypoglycemia. Journal of Perinatology. 40(12). 1841–1848. 1 indexed citations

Park, Sehhoon, Joonho Shim, Peter G. Mortimer, et al.. (2020). Biomarker‐driven phase 2 umbrella trial study for patients with recurrent small cell lung cancer failing platinum‐based chemotherapy. Cancer. 126(17). 4002–4012. 28 indexed citations

Cortes, Jörge E., Kenji Tamura, Daniel J. DeAngelo, et al.. (2018). Phase I studies of AZD1208, a proviral integration Moloney virus kinase inhibitor in solid and haematological cancers. British Journal of Cancer. 118(11). 1425–1433. 83 indexed citations

Boehm, Daniela, Grégory Camus, Andrea Gramatica, et al.. (2017). SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency. Cell Host & Microbe. 21(5). 569–579.e6. 80 indexed citations

Cohen, Deirdre Jill, Elda Grabocka, Dafna Bar‐Sagi, Robert Godin, & Lawrence P. Leichman. (2017). A phase Ib study combining irinotecan with AZD1775, a selective WEE 1 kinase inhibitor, in RAS/RAF mutated metastatic colorectal cancer patients who progressed on first line therapy.. Journal of Clinical Oncology. 35(15_suppl). TPS3627–TPS3627. 5 indexed citations

Gray, Jhanelle E., Tawee Tanvetyanon, Ben Creelan, et al.. (2017). Phase II trial of AZD1775 in combination with carboplatin and paclitaxel in stage IV squamous cell lung cancer (sqNSCLC): Preliminary results.. Journal of Clinical Oncology. 35(15_suppl). e20672–e20672. 1 indexed citations

10.

Cortes, Jörge E., Kenji Tamura, Daniel J. DeAngelo, et al.. (2016). Abstract CT147: Phase I studies of AZD1208, a PIM kinase inhibitor, in patients with recurrent or refractory acute myelogenous leukemia or advanced solid tumors. Cancer Research. 76(14_Supplement). CT147–CT147. 1 indexed citations

11.

Hwang, Rosa F., Todd T. Moore, Maureen M. Hattersley, et al.. (2012). Inhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer. Molecular Cancer Research. 10(9). 1147–1157. 82 indexed citations

12.

Yang, Bin, Alexander W. Hird, Daniel Russell, et al.. (2012). Discovery of novel hedgehog antagonists from cell-based screening: Isosteric modification of p38 bisamides as potent inhibitors of SMO. Bioorganic & Medicinal Chemistry Letters. 22(14). 4907–4911. 15 indexed citations

13.

Ferguson, Andrew D., Nicholas Larsen, Tina Howard, et al.. (2011). Structural Basis of Substrate Methylation and Inhibition of SMYD2. Structure. 19(9). 1262–1273. 154 indexed citations

14.

Oxburgh, Leif, Andrew T. Dudley, Robert Godin, et al.. (2005). BMP4 substitutes for loss of BMP7 during kidney development. Developmental Biology. 286(2). 637–646. 58 indexed citations

15.

Schnabel, Catherine A., Robert Godin, & Michael L. Cleary. (2003). Pbx1 regulates nephrogenesis and ureteric branching in the developing kidney. Developmental Biology. 254(2). 262–276. 89 indexed citations

16.

Godin, Robert, Elizabeth J. Robertson, & Andrew T. Dudley. (1999). Role of BMP family members during kidney development. The International Journal of Developmental Biology. 43(5). 405–411. 66 indexed citations

17.

Dudley, Andrew T., Robert Godin, & Elizabeth J. Robertson. (1999). Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes & Development. 13(12). 1601–1613. 225 indexed citations

18.

Godin, Robert, Norma T. Takaesu, Elizabeth J. Robertson, & Andrew T. Dudley. (1998). Regulation of BMP7 expression during kidney development. Development. 125(17). 3473–3482. 127 indexed citations

19.

Godin, Robert, et al.. (1997). Specification of endoderm in the sea urchin embryo. Mechanisms of Development. 67(1). 35–47. 8 indexed citations

20.

Godin, Robert, Lisa A. Urry, & Susan G. Ernst. (1996). Alternative Splicing of theEndo16Transcript Produces Differentially Expressed mRNAs during Sea Urchin Gastrulation. Developmental Biology. 179(1). 148–159. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact